The corporate venture capital (CVC) landscape in Q1 2025 reflects a strategic shift toward selective, high-impact investments, as detailed in CB Insights’ State of CVC Q1’25 Report.
With global CVC-backed deal volume dropping to a seven-year low, corporations are prioritizing quality over quantity, channeling larger sums into fewer, carefully chosen opportunities.
Despite the decline in deal count, funding levels remain robust, driven by mega-rounds and a relentless focus on artificial intelligence (AI), particularly in the United States.
In Q1 2025, global CVC-backed funding reached $15.7 billion across 773 deals, marking a 10% quarter-over-quarter (QoQ) decline in deal volume—the lowest since 2018.
However, the average deal size surged 31% year-to-date to $27.1 million, signaling that CVCs are making bigger bets on high-potential startups.
Mega-rounds (deals worth $100 million or more) accounted for 51% of total funding, with 33 such deals closed, tying for the highest quarterly total since Q3’22.
This concentration of capital underscores a disciplined approach, with CVCs favoring startups that align closely with their strategic goals, particularly in AI-driven innovation.
AI remains the dominant force in CVC activity, capturing a record-high share of both deals and funding.
In Q1 2025, AI companies secured 20% of all venture deals globally, totaling 1,134 deals.
Notable mega-rounds included investments in AI infrastructure players like Poolside ($500 million Series B, backed by venture arms of Citigroup, HSBC, and Nvidia) and Lightmatter ($400 million Series D, backed by GV).
Beyond core AI infrastructure, CVCs are increasingly targeting specialized applications, such as AI agents for enterprise and industrial use, and solutions for e-commerce, finance, and defense.
The report highlights that 63% of organizations surveyed in December 2024 prioritize AI agents, which can autonomously handle complex tasks like sales prospecting and compliance decision-making.
Geographically, the U.S. continues to lead, with $10.5 billion in CVC-backed funding, followed by Europe ($2.6 billion) and Asia ($1.3 billion).
The U.S. dominance is fueled by AI-focused investments, with defense tech provider Anduril raising a $1.5 billion Series F round (backed by Franklin Venture Partners) and AI chip developer Groq securing a $640 million Series D (backed by Samsung Catalyst).
Meanwhile, Asia’s CVC activity remains subdued, particularly in China, where funding slipped to $0.2 billion due to economic challenges and regulatory constraints.
Japan, however, bucks the trend, with active CVCs like Mitsubishi UFJ Capital and SMBC Venture Capital driving dealmaking.
Early-stage dealmaking is another bright spot, capturing 66% of CVC deals in 2024, the highest share in over a decade.
Biotech startups, such as City Therapeutics and Axonis, drew significant Series A rounds, reflecting CVCs’ interest in forming long-term partnerships with emerging players.
This focus on early-stage investments, coupled with larger deal sizes, suggests that CVCs are positioning themselves to capture value from the next wave of disruptive technologies.
Looking ahead, CB Insights predicts that CVCs will continue to prioritize AI, energy solutions for AI infrastructure, and early-stage opportunities in 2025.
As deal volume contracts, the emphasis on strategic alignment and sustainable business models will define the next phase of corporate venture capital, with AI at its core.
